180 related articles for article (PubMed ID: 17916200)
1. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy.
Smith G; Wilkie MJ; Deeni YY; Farr PM; Ferguson J; Wolf CR; Ibbotson SH
Br J Dermatol; 2007 Dec; 157(6):1230-4. PubMed ID: 17916200
[TBL] [Abstract][Full Text] [Related]
2. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
3. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
4. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
Speight EL; Farr PM
Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.
Bastiaens MT; ter Huurne JA; Kielich C; Gruis NA; Westendorp RG; Vermeer BJ; Bavinck JN;
Am J Hum Genet; 2001 Apr; 68(4):884-94. PubMed ID: 11254446
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrow band (TL-01) UVB phototherapy.
Smith G; Weidlich S; Dawe RS; Ibbotson SH
Pharmacogenet Genomics; 2011 Apr; 21(4):217-24. PubMed ID: 20802377
[TBL] [Abstract][Full Text] [Related]
8. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Mitra D; Luo X; Morgan A; Wang J; Hoang MP; Lo J; Guerrero CR; Lennerz JK; Mihm MC; Wargo JA; Robinson KC; Devi SP; Vanover JC; D'Orazio JA; McMahon M; Bosenberg MW; Haigis KM; Haber DA; Wang Y; Fisher DE
Nature; 2012 Nov; 491(7424):449-53. PubMed ID: 23123854
[TBL] [Abstract][Full Text] [Related]
9. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.
Nan H; Qureshi AA; Hunter DJ; Han J
Br J Dermatol; 2008 Aug; 159(2):314-21. PubMed ID: 18510673
[TBL] [Abstract][Full Text] [Related]
10. The time-course of psoralen ultraviolet A (PUVA) erythema.
Ibbotson SH; Farr PM
J Invest Dermatol; 1999 Sep; 113(3):346-50. PubMed ID: 10469332
[TBL] [Abstract][Full Text] [Related]
11. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
Kirby B; Buckley DA; Rogers S
Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
[TBL] [Abstract][Full Text] [Related]
12. Improved prediction of the minimal phototoxic dose in PUVA therapy.
Sakuntabhai A; Matthews JN; Farr PM
Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
[TBL] [Abstract][Full Text] [Related]
13. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
14. Time course of ultraviolet B-induced erythema in people with red hair harbouring homozygous melanocortin 1 receptor mutations.
Ha TK; Waterston K; Bisset Y; Ray A; Rees JL
Exp Dermatol; 2003 Aug; 12(4):514-7. PubMed ID: 12930311
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
16. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.
Duffy DL; Box NF; Chen W; Palmer JS; Montgomery GW; James MR; Hayward NK; Martin NG; Sturm RA
Hum Mol Genet; 2004 Feb; 13(4):447-61. PubMed ID: 14709592
[TBL] [Abstract][Full Text] [Related]
17. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
18. Unexpectedly severe acute radiotherapy side effects are associated with single nucleotide polymorphisms of the melanocortin-1 receptor.
Fogarty GB; Muddle R; Sprung CN; Chen W; Duffy D; Sturm RA; McKay MJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1486-92. PubMed ID: 19932942
[TBL] [Abstract][Full Text] [Related]
19. Predictive testing of the melanocortin 1 receptor for skin cancer and photoaging.
Lynde CW; Sapra S
Skin Therapy Lett; 2010 Jan; 15(1):5-7. PubMed ID: 20066389
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status.
Naysmith L; Waterston K; Ha T; Flanagan N; Bisset Y; Ray A; Wakamatsu K; Ito S; Rees JL
J Invest Dermatol; 2004 Feb; 122(2):423-8. PubMed ID: 15009725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
